Stoke Therapeutics, Inc. STOK Operating margin

Operating margin at other companies

Ionis PharmaceuticalsIONS

-68%-234pp

Jazz PharmaceuticalsJAZZ

-11.9%-28.1pp

Xenon PharmaceuticalsXENE

-4,974.3%—

Praxis Precision Medicines, Inc.PRAX

-3,927.5%-1,497pp

CalAmpCAMP

-1,335.2%-512pp

Harmony Biosciences Holdings, Inc.HRMY

21.1%-5.1pp

FAQ

What is Stoke Therapeutics, Inc.'s operating margin?

Stoke Therapeutics, Inc. (STOK) reported operating margin of -577.5% in Q1 2026.

How has Stoke Therapeutics, Inc.'s operating margin changed year-over-year?

Stoke Therapeutics, Inc.'s operating margin decreased by 2982.7% year-over-year, from 20% to -577.5%.

What is the long-term trend for Stoke Therapeutics, Inc.'s operating margin?

Over 3 years (2022 to 2025), Stoke Therapeutics, Inc.'s operating margin has grown at a -76.3% compound annual growth rate (CAGR), from -841.3% to -11.2%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.